Sanofi Stock News

The EMA accepts Sanofi's (SNY) regulatory submission seeking approval for olipudase alfa, a potential treatment for acid sphingomyelinase deficiency.

DUBLIN--(BUSINESS WIRE)--The "Immunosuppressants Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global immunosuppressants market is expected to grow from $15.04 billion in 2020 to $16.5 billion in 2021 at a compound annual growth rate (CAGR) of 9.7%. The market is expected to reach $25.33 billion in 2025 at a CAGR of 11%. Major players in the immunosuppressant market are Astellas Pharma, GlaxoSmithKline, Bristol Mye

Janney Capital Management LLC reduced its holdings in shares of Sanofi (NASDAQ:SNY) by 1.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 194,718 shares of the companys stock after selling 3,477 shares during the quarter. Janney Capital Management LLCs holdings []

Market trends for Ceftaroline Fosamil around the world, including consumer and producer trends. In the global Ceftaroline Fosamil market, value chain analysis covers participants from raw material suppliers to downstream buyers. Major market opportunities and challenges to be focused on

The global Dalbavancin market is expected a CAGR of 19.8% from 2021 to 2027. Because of technological advancements, the dalbavancin market is expected to grow. However, as people become more aware of the presence of dalbavancin antibiotics, their ignorance has

Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players. Vaccines Market Key Players Studied in this Report Are GlaxoSmithKline plc. (Brentford, United Kingdom), Sanofi (Paris, France), Pfizer Inc. (New York, United States), Merck & Co., Inc. (New Jersey, United States), Novartis AG (Basel, Switzerland), Emergent BioSolutions, Inc. (Maryland, United States), CSL Limited (Melbourne, Australia), Inovio Pharmaceuticals, Inc. (Pennsylvania, United States), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Osaka, Japan), Other Prominent Players.

A Proteins play a crucial role in preserving both the physical and practical aspects of a specific creature. Long-chain of amino acids brands up a protein element and controls all biological functions such as metabolic responses, DNA repetition, and other

Buy Now According to the research report, Global Disinfection and Hand Sanitizer Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027 states that the Reckitt Benckiser, Shanghai Jahwa Corporation, Amway, P&G, Medline, Unilever, Chattem (Sanofi), Lion Corporation, 3M, Henkel, GOJO Industries, Kao, Bluemoon, and many more are some Read More » The post Growing Personal Hygiene Among People Will Drive The Global Disinfection And Hand Sanitizer Market Outlook: Ken Research appeared first on Ken Research .

GSK Singapore is contracted to supply the Government of Singapore with additional doses of sotrovimab, following the first purchase placed by the Ministry of Health (MOH) in June 2021 Sotrovimab was approved by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization in June 2021 SINGAPORE , Dec. 7, 2021 /PRNewswire/ -- GlaxoSmithKline Singapore announced an agreement with the Government of Singapore to supply additional doses of sotrovimab. Sotrovimab is an investigational single-dose monoclonal antibody developed in partnership with Vir Biotechnology, for the treatment of patients with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19. This follows the initial purchase agreement signed between GSK Singapore and the government in June 2021 . Priya Kudva Menon , VP and General Manager, GSK Singapore, said: "As we move into the endemic stage of COVID-19 in Singapore , it is clear that multiple treatment options are needed to manage the impact of this virus on people and communities, in addition to vaccinations and other preventative measures.

Deep pipeline in the next few years explained. Vaccine portfolio.

The global Chloroquine Phosphate market size was US$ 189 million in 2020 and it is expected to reach US$ 66 million by the end of 2027, with a CAGR of -11.4% during 2021-2027. Chloroquine phosphate (also known as chloroquine) is

Key Companies Covered in the Heparin Market Research Report Are GlaxoSmithKline plc, Pfizer Inc., Aspen Holdings, Baxter International Inc., Fresenius Kabi AG, Amphastar Pharmaceuticals, Inc., Mylan N.V., Sanofi, LEO Pharma A/S, B.Braun Melsungen AG, and other key market players. Key Companies Covered in the Heparin Market Research Report Are GlaxoSmithKline plc, Pfizer Inc., Aspen Holdings, Baxter International Inc., Fresenius Kabi AG, Amphastar Pharmaceuticals, Inc., Mylan N.V., Sanofi, LEO Pharma A/S, B.Braun Melsungen AG, and other key market players.

The global Monoclonal Antibody Treatment market size is projected a CAGR of 13.3% during 2021-2027. Increased cancer prevalence, increased demand for cost-effective biosimilar monoclonal antibodies, high demand for biologics, and increased genomics R&D activities, as well as the introduction of

The global Narcotic Analgesics market size is projected a CAGR of 4.6% during 2021-2027. The ageing population''s frequent pain and aches, rising incidences of cardiovascular disease (CVD), cancer, and arthritis, and rising public and private sector R&D spending, with a